NO913035L - (2r)-2-(di(2-propyl)fosfonylmetoksy)-3-p-toluensulfonyloksy-1-trimetylacetoksypropan, fremgangsmaate for fremstilling og anvendelse derav. - Google Patents

(2r)-2-(di(2-propyl)fosfonylmetoksy)-3-p-toluensulfonyloksy-1-trimetylacetoksypropan, fremgangsmaate for fremstilling og anvendelse derav.

Info

Publication number
NO913035L
NO913035L NO91913035A NO913035A NO913035L NO 913035 L NO913035 L NO 913035L NO 91913035 A NO91913035 A NO 91913035A NO 913035 A NO913035 A NO 913035A NO 913035 L NO913035 L NO 913035L
Authority
NO
Norway
Prior art keywords
trimetylacetoxypropane
toluensulphonyloxy
phosphonylmetoxy
propyl
procedure
Prior art date
Application number
NO91913035A
Other languages
English (en)
Other versions
NO913035D0 (no
Inventor
Petr Alexander
Antonin Holy
Hana Dvorakova
Original Assignee
Ceskoslovenska Akademie Ved
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceskoslovenska Akademie Ved filed Critical Ceskoslovenska Akademie Ved
Publication of NO913035D0 publication Critical patent/NO913035D0/no
Publication of NO913035L publication Critical patent/NO913035L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/6512Six-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO91913035A 1990-08-06 1991-08-05 (2r)-2-(di(2-propyl)fosfonylmetoksy)-3-p-toluensulfonyloksy-1-trimetylacetoksypropan, fremgangsmaate for fremstilling og anvendelse derav. NO913035L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS903871A CS276072B6 (en) 1990-08-06 1990-08-06 (2R)-2-/DI(2-PROPYL)PHOSPHONYLMETHOXY/-3-p-TOLUENESULFONYLOXY -1- TRIMETHYLACETOXYPROPANE AND PROCESS FOR PREPARING THEREOF

Publications (2)

Publication Number Publication Date
NO913035D0 NO913035D0 (no) 1991-08-05
NO913035L true NO913035L (no) 1992-02-07

Family

ID=5380072

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91913035A NO913035L (no) 1990-08-06 1991-08-05 (2r)-2-(di(2-propyl)fosfonylmetoksy)-3-p-toluensulfonyloksy-1-trimetylacetoksypropan, fremgangsmaate for fremstilling og anvendelse derav.

Country Status (13)

Country Link
US (2) US5130427A (no)
EP (1) EP0470809A1 (no)
JP (1) JP2955402B2 (no)
AU (1) AU8149291A (no)
CA (1) CA2046755C (no)
CS (1) CS276072B6 (no)
FI (1) FI913702A7 (no)
IE (1) IE71217B1 (no)
IL (1) IL98849A0 (no)
NO (1) NO913035L (no)
NZ (1) NZ239131A (no)
PT (1) PT98590B (no)
ZA (1) ZA915932B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ284678B6 (cs) * 1991-05-20 1999-01-13 Ústav Organické Chemie A Biochemie Avčr Di(2-propyl)estery 1-fluor-2-fosfonomethoxy-3-p -toluensulfonyloxypropanů, způsob jejich přípravy a použití
US6057305A (en) * 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
JP2532818B2 (ja) 1993-02-01 1996-09-11 松下電器産業株式会社 対物レンズおよび光ヘッド装置
US5502177A (en) * 1993-09-17 1996-03-26 Gilead Sciences, Inc. Pyrimidine derivatives for labeled binding partners
AU3851601A (en) * 2000-02-18 2001-08-27 Southern Res Inst Methods for synthesizing 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-9h- purin-6-amine
OA12393A (en) 2000-07-21 2006-04-18 Gilead Sciences Inc Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same.
US7214668B2 (en) * 2002-05-13 2007-05-08 Metabasis Therapeutics, Inc. Phosphonic acid based prodrugs of PMEA and its analogues
AU2003235501A1 (en) * 2002-05-13 2003-11-11 Metabasis Therapeutics, Inc. PMEA and PMPA cyclic producing synthesis
CN1964967B (zh) * 2004-06-08 2014-04-16 症变治疗公司 路易斯酸介导的环状酯的合成
BR112013014485B1 (pt) 2010-12-10 2021-03-30 Sigmapharm Laboratories, Llc Composições farmacêuticas compreendendo pró-fármacos análogos de nucleotídeos de fosfonato ativos por via oral e sistema de embalagem de recipiente/fechamento contendo as ditas composições
WO2013095684A1 (en) 2011-12-22 2013-06-27 Geron Corporation Guanine analogs as telomerase substrates and telomere length affectors
AU2015217221A1 (en) 2014-02-13 2016-08-11 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
JP2017520545A (ja) 2014-07-02 2017-07-27 リガンド・ファーマシューティカルズ・インコーポレイテッド プロドラッグ化合物およびそれらの使用
CA3087932A1 (en) 2018-01-09 2019-07-18 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof
JP7151348B2 (ja) * 2018-10-03 2022-10-12 日本製鉄株式会社 金属板用塗料およびこれを用いた塗装金属板の製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868187A (en) * 1980-09-16 1989-09-19 Syntex (U.S.A.) Inc. Anti-viral N-substituted pyrimidines
US4816447A (en) * 1981-08-26 1989-03-28 Merck & Co., Inc. Anti-viral guanine compounds
CS233665B1 (en) * 1983-01-06 1985-03-14 Antonin Holy Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
AU8092587A (en) * 1986-11-18 1988-05-19 Bristol-Myers Squibb Company Synthesis of purin-9-ylalkylenoxymethyl phosphonic acids
US4968686A (en) * 1988-04-08 1990-11-06 The Regents Of The University Of Michigan Acyclic pyrrolo [2,3-d]pyrimidine analogs as antiviral agents
US4927830A (en) * 1988-04-08 1990-05-22 The Regents Of The University Of Michigan Acyclic pyrrolo[2,3-D]pyrimidine analogs as antiviral agents
DE69132276T2 (de) * 1990-08-10 2001-03-01 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic, Prag/Praha Verfahren zur herstellung von nukleotiden

Also Published As

Publication number Publication date
NO913035D0 (no) 1991-08-05
IE71217B1 (en) 1997-02-12
IE912758A1 (en) 1992-02-12
CA2046755A1 (en) 1992-02-07
USRE35558E (en) 1997-07-08
FI913702A0 (fi) 1991-08-02
FI913702L (fi) 1992-02-07
PT98590B (pt) 1999-04-30
FI913702A7 (fi) 1992-02-07
NZ239131A (en) 1994-04-27
ZA915932B (en) 1992-04-29
JP2955402B2 (ja) 1999-10-04
AU8149291A (en) 1992-02-13
EP0470809A1 (en) 1992-02-12
JPH05230087A (ja) 1993-09-07
US5130427A (en) 1992-07-14
CS387190A3 (en) 1992-03-18
CA2046755C (en) 2002-02-12
IL98849A0 (en) 1992-07-15
PT98590A (pt) 1992-06-30
CS276072B6 (en) 1992-03-18

Similar Documents

Publication Publication Date Title
DZ1763A1 (fr) Composition vaccinantes.
NO902658L (no) N-fenylpyrazolderivater, preparater og anvendelse derav.
MX9102473A (es) Agentes farmaceuticos.
NO902073L (no) Pumpeapparat for biomedisinsk bruk.
MX9203481A (es) Formulaciones.
FI920152A0 (fi) Kirurgisk borrschablon.
FI921142L (fi) Gelformulationer.
DE69021383D1 (de) Medizinisches beatmungsgerät.
DE59007669D1 (de) Lithotriptor.
NO913035D0 (no) (2r)-2-(di(2-propyl)fosfonylmetoksy)-3-p-toluensulfonyloksy-1-trimetylacetoksypropan, fremgangsmaate for fremstilling og anvendelse derav.
DE59006562D1 (de) Endoskop, insbesondere Resektoskop.
NO892869L (no) Heteropolysakkarider, fremgangsmaate for deres fremstilling og anvendelse.
NO900943D0 (no) Kopolymerer, fremgangsmaate for deres fremstilling og anvendelse.
DE69110750D1 (de) Zytotoxisches Testverfahren.
TR199501082A2 (tr) Farmasötik formülasyonlar.
DE69112449D1 (de) Endoskop.
MX9200532A (es) Agente farmaceuticos.
DE59104783D1 (de) Patientenuntersuchungstisch.
MX9205821A (es) Pirimidinil- y triazinileteres y -tioeteres y procedimiento para su preparacion.
FI923371A0 (fi) En farmaceutisk formulation.
DE69103824D1 (de) Patientenliegetische.
DK0522059T3 (da) Fastholdelsesindretning og forbindelsesindretning, som indbefatter fastholdelsesindretningen
TR25921A (tr) PESTISID ETKINLIGI HAIZ PESTISID ÖZELLIKTE BISIKLOOKTANLAR,BUNLARI IHTIVA EDEN FORMüLASYONLAR VE HAZIRLANMALARINA MAHSUS USULLER.
NO910590D0 (no) Hydratiserte silikater, fremgangsmaate for deres fremstilling og anvendelse.
IT9022507A0 (it) Procedimento per la preparazione di n-(26ammino63,5-dibromo-benzil)-trans-4-amminocicloesanolo3.